Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Notes Payables (2016 - 2022)

Nutex Health (NUTX) has disclosed Notes Payables for 7 consecutive years, with $877172.0 as the latest value for Q4 2021.

  • For Q4 2021, Notes Payables rose 2169.47% year-over-year to $877172.0; the TTM value through Dec 2021 reached $877172.0, up 2169.47%, while the annual FY2021 figure was $877172.0, 2169.47% up from the prior year.
  • Notes Payables hit $877172.0 in Q4 2021 for Nutex Health, down from $1.1 million in the prior quarter.
  • Across five years, Notes Payables topped out at $1.1 million in Q3 2021 and bottomed at $38651.0 in Q4 2020.
  • Average Notes Payables over 5 years is $321780.6, with a median of $66377.0 recorded in 2017.
  • Year-over-year, Notes Payables tumbled 93.64% in 2017 and then skyrocketed 2169.47% in 2021.
  • Nutex Health's Notes Payables stood at $52500.0 in 2017, then soared by 237.25% to $177055.0 in 2018, then skyrocketed by 179.91% to $495593.0 in 2019, then crashed by 92.2% to $38651.0 in 2020, then surged by 2169.47% to $877172.0 in 2021.
  • According to Business Quant data, Notes Payables over the past three periods came in at $877172.0, $1.1 million, and $727072.0 for Q4 2021, Q3 2021, and Q2 2021 respectively.